Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

Eyewire TV February 16th 2022 thumbnail

Introduction

Genentech Provides 2-year, Phase 3 Data for Vabysmo and Susvimo thumbnail

Genentech Provides 2-year, Phase 3 Data for Vabysmo and Susvimo

Novartis Presents New Data From Three Phase 3 Trials of Beovu in DME thumbnail

Novartis Presents New Data From Three Phase 3 Trials of Beovu in DME

Regeneron Presents Phase 2 Results for High-Dose Aflibercept in Wet AMD thumbnail

Regeneron Presents Phase 2 Results for High-Dose Aflibercept in Wet AMD


Previous EyewireTV Episodes